Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.33 USD
Change Today -0.13 / -5.28%
Volume 1.2M
As of 5:20 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Leland F. Wilson

Former Chief Executive Officer and Director, VIVUS Inc.
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 1 different industries.

See Board Relationships
70$4,575,899
As of Fiscal Year 2013

Background*

Mr. Leland F. Wilson serves as a Member of Industry Advisory Board at Valence Life Sciences. He served as the Chief Executive Officer at VIVUS Inc. from November 1991 to July 19, 2013. Previously, Mr. Wilson served as a President of VIVUS Inc. from April 1991 to November 3, 2009. He served as an Independent Director at VIVUS Inc. from April 1991 to July 2013. He served as a Vice President of Marketing and Corporate Development at Genelabs Technologies, Inc. from 1989 ...

Read Full Background

Corporate Headquarters*

351 East Evelyn Avenue
Mountain View, California 94041

United States

Phone: 650-934-5200
Fax: --

Board Members Memberships*

1991-2013
Former Chief Executive Officer and Director

Education*

MS
Pennsylvania State University
BS
Pennsylvania State University

Other Affiliations*

Annual Compensation*

Salary$459,355
Total Annual Compensation$459,355

Stock Options*

All Other Compensation$2,453,637
Exercised Options2,095,315
Exercised Options Value$8,990,522
Exercisable Options541,000
Total Value of Options$8,990,522
Total Number of Options2,636,315

Total Compensation*

Total Annual Cash Compensation$2,912,992
Total Short Term Compensation$459,355
Other Long Term Compensation$2,453,637
Total Calculated Compensation$4,575,899
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VVUS:US $2.33 USD -0.13

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$725.0K
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
--
Zubair Ahmed Managing Director, Senior Vice President of Indian Sub Continent, Executive Director and Member of Whistle Blower Committee
GlaxoSmithKline Consumer Healthcare Limited
97.4M
Michael A. Narachi M.S., M.B.A.Chief Executive Officer, President and Director
Orexigen Therapeutics, Inc.
$640.6K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIVUS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.